06 versus 0.48, respectively). Exposure alone had an effect, size of 0.81, nonsignificantly different, from placebo. Effect sizes tended to improve at follow-ups. CBT effectiveness was confirmed by Gould’s metaanalysis109 in which pharmacotherapy (11 studies) had an effect, size of 0.62 versus placebo, while CBT (16 studies) reached 0.74 Inhibitors,research,lifescience,medical compared with control conditions. In summary, meta-analytic approaches of the research suggest, that CBT is effective and exposure is a crucial component, of CBT, while

the effect, of CT remains in discussion. Medication and CBT in social phobia Main outcome studies Buspirone was less effective than CBT at 6 weeks in reducing performance anxiety in musicians.110 Gel ernter et al111 compared four groups: CBT, phenelzine, alprazolam, and placebo. All four groups received instruction of self-exposure. All groups improved

significantly at 2 months with few differences between them. However, this equal improvement could have resulted from the exposure instructions. BT was superior to atenolol at Inhibitors,research,lifescience,medical 3 and 6 months.112 A positive combination of exposure Inhibitors,research,lifescience,medical with sertraline was found at 24 weeks. Combination was superior to placebo, but. equal to sertraline alone.113 Few differences, but, in favor of clonazepam, were found in a comparison of this BDZ with behavioral group therapy114; patients were only rated at. 4, 8, and 12 weeks. CBGT was found to be superior to pill-Gedatolisib ic50 placebo and educational group therapy, but. slightly inferior to phenelzine on Inhibitors,research,lifescience,medical some measures at the 12 weeks’ evaluation in a randomized trial.115 Follow-up data found that, after withdrawal of the medication, CBGT was better, especially in generalized social phobia.116 Meta-analysis of CBT and medication A meta-analysis117 of psychological and pharmacological treatments for social phobia

was conducted: 108 treatment-outcome trials were entered in this meta-analysis. Eleven treatment, conditions were compared: waiting-list control, pill placebo, BDZ, SSRIs, monoamine oxidase inhibitors, Inhibitors,research,lifescience,medical attention placebo, exposure, cognitive restructuring, and applied relaxation. The most, consistently effective treatments for social phobias were pharmacotherapies. BDZs and SSRIs were equally more effective than control conditions. Dropout rates were similar among all the active treatment conditions. Oxygenase The durability of treatment, gains for pharmacotherapies was not assessed because of an insufficient number of drug studies with follow-up data. The treatment gains of CBT, although moderate, continued during the follow-up period. BDZs and SSRIs seem to be effective treatments for social phobia, at, least in the short, term. The authors recommended assessment, of the long-term outcome and evaluation of the inclusion of a CBT during the drug-tapering period. Psychoanalytic therapies in performance anxiety A randomized study by Paul118 in 1.